Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hood

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Cellular Physiology|March 12, 2008
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edemaJohn Doukas, Sankaranarayana Mahesh, Naoyasu Umeda, et al.
BMC Nephrology|July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology|August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
The design and preliminary structure-activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymesJianguo Cao, Richard Fine, Colleen Gritzen, et al.
Nature Communications|October 19, 2017
Controlling the bioactivity of a peptide hormone in vivo by reversible self-assemblyMyriam M Ouberai, Ana L Gomes Dos Santos, Sonja Kinna, et al.
Current Topics in Medicinal Chemistry|August 5, 2008
Inhibitors of ABL and the ABL-T315I mutationGlenn Noronha, Jianguo Cao, Chun P Chow, et al.
Mabs|November 12, 2016
The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycanPing Tsui, Daniel R Higazi, Yanli Wu, et al.
BMC Nephrology|July 23, 2014
Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study)Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Peptides|March 21, 2021
Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean miceSam G Galvin, Pierre Larraufie, Richard G Kay, et al.
Mabs|January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancerDarren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cellular Physiology|March 12, 2008
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edemaJohn Doukas, Sankaranarayana Mahesh, Naoyasu Umeda, et al.
BMC Nephrology|July 17, 2013
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
BMC Nephrology|August 8, 2015
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular massJoanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
The design and preliminary structure-activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymesJianguo Cao, Richard Fine, Colleen Gritzen, et al.
Nature Communications|October 19, 2017
Controlling the bioactivity of a peptide hormone in vivo by reversible self-assemblyMyriam M Ouberai, Ana L Gomes Dos Santos, Sonja Kinna, et al.
Current Topics in Medicinal Chemistry|August 5, 2008
Inhibitors of ABL and the ABL-T315I mutationGlenn Noronha, Jianguo Cao, Chun P Chow, et al.
Mabs|November 12, 2016
The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycanPing Tsui, Daniel R Higazi, Yanli Wu, et al.
BMC Nephrology|July 23, 2014
Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study)Joanna Leigh Dunlop, Alain Charles Vandal, Janak Rashme de Zoysa, et al.
Peptides|March 21, 2021
Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean miceSam G Galvin, Pierre Larraufie, Richard G Kay, et al.
Mabs|January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancerDarren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
Pageof 5